share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股SEC公告 ·  09/11 05:04
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 09/10/2024, with an aggregate market value of $92,498.87. The shares were originally acquired on 07/18/2023 through a stock option exercise from the issuer, with payment made in cash on the same date. This planned sale follows a series of transactions over the past three months where a total of 90,000 shares were sold for gross proceeds of $687,667.20.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 09/10/2024, with an aggregate market value of $92,498.87. The shares were originally acquired on 07/18/2023 through a stock option exercise from the issuer, with payment made in cash on the same date. This planned sale follows a series of transactions over the past three months where a total of 90,000 shares were sold for gross proceeds of $687,667.20.
Recursion Pharmaceuticals, Inc.官員Secora Michael計劃在2024年09/10賣出15,000股A類股，預計市值爲$92,498.87。這些股票最初是通過期權行使從發行人手中於2023年07/18購得，當天以現金支付。這次計劃的出售是在過去三個月的一系列交易之後進行的，總共賣出90,000股，總收入爲$687,667.20。
Recursion Pharmaceuticals, Inc.官員Secora Michael計劃在2024年09/10賣出15,000股A類股，預計市值爲$92,498.87。這些股票最初是通過期權行使從發行人手中於2023年07/18購得，當天以現金支付。這次計劃的出售是在過去三個月的一系列交易之後進行的，總共賣出90,000股，總收入爲$687,667.20。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。